LISA CWIKLA: Open Payments
NPI 1437825684 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 83 payments from 14 companies in 2025. Trend: 2023 $825 · 2024 $1,349 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $248 |
| Axsome Therapeutics, Inc. | 8 | $224 |
| Otsuka America Pharmaceutical, Inc. | 9 | $176 |
| Neurocrine BioSciences, Inc. | 12 | $173 |
| ABBVIE INC. | 13 | $161 |
| Tris Pharma Inc | 12 | $153 |
| Teva Pharmaceuticals USA, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Lundbeck LLC | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
Products named: REXULTI, Auvelity, ARISTADA, INGREZZA, VRAYLAR, Dyanavel XR, TRINTELLIX, UZEDY.
Industry payments across WI — which companies pay providers there.
